MUTYH and the mismatch repair system: partners in crime?

Renée C Niessen1, Rolf H Sijmons, J Ou

  • 1Department of Medical Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Human Genetics
|January 13, 2006
PubMed

Insights

Monoallelic MUTYH mutations combined with mismatch repair (MMR) gene missense mutations, particularly in MSH6, may increase cancer risk. Further research is needed to confirm this interaction in colorectal and endometrial cancer susceptibility.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Biallelic MUTYH mutations are linked to colorectal cancer.
  • The role of monoallelic MUTYH mutations in cancer risk is unclear.
  • MUTYH protein interacts with the mismatch repair (MMR) system.

Purpose of the Study:

  • To investigate the prevalence of monoallelic MUTYH mutations in carriers of germline MMR mutations.
  • To test the hypothesis that combined monoallelic MUTYH and MMR gene mutations increase cancer risk.

Main Methods:

  • Studied 76 patients with colorectal or endometrial cancer and germline MMR mutations (40 truncating, 36 missense).
  • Compared MUTYH mutation frequencies with 134 cancer patients without MMR mutations and published controls.
  • Analyzed MUTYH mutation prevalence in relation to MMR mutation type (truncating vs. missense).

Main Results:

  • One monoallelic MUTYH mutation found in 40 truncating MMR mutation carriers (2.5%).
  • Five monoallelic MUTYH mutations found in 36 missense MMR mutation carriers (14%), with four in MSH6 missense carriers (20%).
  • Significantly higher frequency of monoallelic MUTYH mutations in missense MMR mutation carriers compared to controls (P = 0.001) and Dutch cancer patients (P = 0.002).

Conclusions:

  • Monoallelic MUTYH mutations are more frequent in patients with missense MMR gene mutations.
  • The combination of missense MMR gene mutations (especially MSH6) and monoallelic MUTYH mutations may increase cancer risk.
  • Further studies are warranted to confirm the synergistic effect of MMR and MUTYH gene mutations on cancer susceptibility.